• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 029 Publication Date: 08/20/2012 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 3-55: ASTM F1830-97 (2005), Standard Practice for Selection of Blood for In Vitro Evaluation of Blood Pumps. (Cardiovascular)

Date of Standard: 2005. 
Address of Standards Organization:
  ASTM International (ASTM)
  100 Barr Harbor Drive
  West Conshohocken, PA 19428-2959
 
CDRH Office and Division Associated with Recognized Standards:
OFFICE OF DEVICE EVALUATION (ODE)
DIVISION OF CARDIOVASCULAR DEVICES (DCD)
Devices Affected:
Continuous Flow Blood Pumps for Short Term (<=6HRS) Durations of Use
Processes Affected:
510(k), PMA, IDE, PDP, HDE, Design Control Input, Quality System Regulation
Type of Standard:
 Vertical
Extent of Recognition:
Complete Standard

NOTE: In general, this standard provides some basic guidelines for the selection of blood to be used in performing hemolysis testing on blood pumps.
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§870.4360 Pump, Blood, Cardiopulmonary Bypass, Non-Roller Type Class 3 KFM
 
Regulation
Number
Device Name Device
Class
Product
Code
§870.4370 Pump, Blood, Cardiopulmonary Bypass, Roller Type Class 2 DWB
 
Relevant Guidance:
There is no relevant guidance developed at this time.
FDA Technical Contacts:
  Richard A. Malinauskas
  FDA/CDRH/OSEL
  WO62, Room 2108 10903 New Hampshire Avenue
  Silver Spring MD 20993
  301/796-2506
  Email: richard.malinauskas.fda.hhs.gov
  Jean E. Rinaldi
  FDA/CDRH/OSEL
  10903 New Hampshire Avenue Building 62, Room 2220
  Silver Spring MD 20993
  301/796-2523
  Email: jean.rinaldi@fda.hhs.gov
-
-